The use of inhibitors as sEH enzyme inhibitors in models with acute kidney injury (AKI), diabetic nephrology (DN), chronic kidney diseases (CKD), hypertension and other renal dysfunctions may present a potential therapy although this needs further experimental studies. The gene discussed is EPHX2; the disease is acute kidney injury.